Exact Mass: 390.1042
Exact Mass Matches: 390.1042
Found 15 metabolites which its exact mass value is equals to given mass value 390.1042,
within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error
0.0002 dalton.
2-(3,4-Dichlorophenyl)-1-(2-(pyrrolidin-1-ylmethyl)piperidin-1-yl)ethanone hydrochloride
2-(3,4-Dichlorophenyl)-1-(2-(pyrrolidin-1-ylmethyl)piperidin-1-yl)ethanone hydrochloride
3-[[[(1-Oxo-2,2-diphenylethyl)amino]-sulfanylidenemethyl]amino]benzoic acid
3-[[[(1-Oxo-2,2-diphenylethyl)amino]-sulfanylidenemethyl]amino]benzoic acid
ethyl 2-anilino-5-(1H-indol-3-ylmethylene)-4-oxo-4,5-dihydro-3-thiophenecarboxylate
ethyl 2-anilino-5-(1H-indol-3-ylmethylene)-4-oxo-4,5-dihydro-3-thiophenecarboxylate
4-(4-Methoxyphenoxy)-2-(4-methylphenyl)-5-thiophen-2-yl-3-pyridazinone
4-(4-Methoxyphenoxy)-2-(4-methylphenyl)-5-thiophen-2-yl-3-pyridazinone
1-[(1S,2aS,8bS)-4-(4-fluorophenyl)sulfonyl-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]ethanone
1-[(1S,2aS,8bS)-4-(4-fluorophenyl)sulfonyl-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]ethanone
1-[(1R,2aS,8bS)-4-(4-fluorophenyl)sulfonyl-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]ethanone
1-[(1R,2aS,8bS)-4-(4-fluorophenyl)sulfonyl-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]ethanone
1-[(1R,2aR,8bR)-4-(4-fluorophenyl)sulfonyl-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]ethanone
1-[(1R,2aR,8bR)-4-(4-fluorophenyl)sulfonyl-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]ethanone
1-[(1S,2aR,8bR)-4-(4-fluorophenyl)sulfonyl-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]ethanone
1-[(1S,2aR,8bR)-4-(4-fluorophenyl)sulfonyl-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]ethanone
BRL 52537 (hydrochloride)
BRL 52537 (hydrochloride)
BRL 52537 hydrochloride is a highly selective κ-Opioid receptor (KOR) agonist with Kis of 0.24 nM and 1560 nM for κ and μ subtypes, respectively. BRL 52537 hydrochloride decreases ischemia-evoked NO production as a potential mechanism of neuroprotection. BRL 52537 hydrochloride attenuates early stroke damage[1].
(1s,7r,9s,11r,13s)-5-bromo-13-hydroxy-2,4,4,9-tetramethyl-3,8-dioxatricyclo[7.2.2.0²,⁷]tridecan-11-yl acetate
(1s,7r,9s,11r,13s)-5-bromo-13-hydroxy-2,4,4,9-tetramethyl-3,8-dioxatricyclo[7.2.2.0²,⁷]tridecan-11-yl acetate
(1r,2s,5s,7s,9r,11s,13r)-5-bromo-13-hydroxy-2,4,4,9-tetramethyl-3,8-dioxatricyclo[7.2.2.0²,⁷]tridecan-11-yl acetate
(1r,2s,5s,7s,9r,11s,13r)-5-bromo-13-hydroxy-2,4,4,9-tetramethyl-3,8-dioxatricyclo[7.2.2.0²,⁷]tridecan-11-yl acetate
5-bromo-13-hydroxy-2,4,4,9-tetramethyl-3,8-dioxatricyclo[7.2.2.0²,⁷]tridecan-11-yl acetate
5-bromo-13-hydroxy-2,4,4,9-tetramethyl-3,8-dioxatricyclo[7.2.2.0²,⁷]tridecan-11-yl acetate
(1s,7r,9s,11r)-5-bromo-13-hydroxy-2,4,4,9-tetramethyl-3,8-dioxatricyclo[7.2.2.0²,⁷]tridecan-11-yl acetate
(1s,7r,9s,11r)-5-bromo-13-hydroxy-2,4,4,9-tetramethyl-3,8-dioxatricyclo[7.2.2.0²,⁷]tridecan-11-yl acetate
